Sygen Pharmaceuticals secures investment from Àrgentil Capital and other co-investors

NIGERIA – Àrgentil Capital Management Limited, a boutique investment banking firm, has announced its equity investment in Sygen Pharmaceuticals Limited that was structured via the sponsors’ investment vehicle, Consumer Growth Partners along with other co-investors. Àrgentil invested in the transaction based on the management teams strong track record in excess of 155 years’ leading and managing operations of FMCG companies in Nigeria and other emerging markets. The healthcare and consumer sector continue to provide significant growth opportunities to companies like Sygen who can deliver quality affordable drugs to a large…

Read More